The BRCA gene is a DNA analysis to identify harmful changes (mutations) in either one of two breast cancer susceptibiltiy genes -BRCA1 and BRCA2.

Women who have inherited mutation in these genes are at an increased risk (70% chance) of developing breast cancer and ovarian cancer compared with the general population.

Mapmygenome’s BRCAMap test covers both BRCA1 and BRCA2 genes (Full sequence analysis for coding regions). Blood specimen is collected from the individual for DNA extraction and analysis (Next Generation Sequencing). Validation by Sanger sequencing for pathogenic variants found (if any).

Price USD 450

This includes:
- Primary Genotype Report
- Personalised Genetic Counseling session (~45 mins)
- Recommendations and guidelines from our counselor. This may include other screening tests if any.